LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹3.83 Cr | ₹4.01 Cr | ₹4.23 Cr | ₹-16 Cr | ₹-12 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LYKA LABS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹3.83 Cr |
Mar2023 | ₹4.01 Cr |
Mar2022 | ₹4.23 Cr |
Mar2021 | ₹-16 Cr |
Mar2020 | ₹-12 Cr |
How is Deferred Tax Assets / Liabilities of LYKA LABS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.83 Cr | -4.54 | |
Mar2023 | ₹4.01 Cr | -5.27 | |
Mar2022 | ₹4.23 Cr | Positive | |
Mar2021 | ₹-16 Cr | Negative | |
Mar2020 | ₹-12 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹546.7 Cr | 3.3% | 5.4% | 32.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 0.3% | -2.6% | 36.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1% | -0.5% | 60.8% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -1.4% | -3.1% | 11.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -3.8% | -4% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | 0.1% | 1.2% | 40.3% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 3.3% |
5.4% |
32.5% |
SENSEX | -0.9% |
-4.3% |
3.7% |
You may also like the below Video Courses